EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Autosomal dominant osteopetrosis

Lynda E Polgreen, Erik A Imel, Michael J Econs

Bone · 2023-05 · 170 · 116723

DOI: 10.1016/j.bone.2023.116723 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bone, 2023-05. Verfasst von Lynda E Polgreen und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: lpolgreen@lundquist.org. Hauptthemen laut MEDLINE: Osteopetrosis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal dominant osteopetrosis (ADO) is the most common form of osteopetrosis. ADO is characterized by generalized osteosclerosis along with characteristic radiographic features such as a "bone-in-bone" appearance of long bones and sclerosis of the superior and inferior vertebral body endplates. Generalized osteosclerosis in ADO typically results from abnormalities in osteoclast function, due most commonly to mutations in the chloride channel 7 (CLCN7) gene. A variety of debilitating complications can occur over time due to bone fragility, impingement of cranial nerves, encroachment of osteopetrotic bone in the marrow space, and poor bone vascularity. There is a wide spectrum of disease phenotype, even within the same family. Currently, there is no disease specific treatment for ADO, so clinical care focuses on monitoring for disease complications and symptomatic treatment. This review describes the history of ADO, the wide disease phenotype, and potential new therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopetrosisHumansMutationOsteoclastsChloride ChannelsGenes, Dominant

Stichwörter der Autor:innen

Genes/dominantOsteopetrosis/epidemiologyOsteopetrosis/geneticsOsteopetrosis/historyOsteopetrosis/pathologyOsteopetrosis/therapy

Substanzen

Chloride ChannelsCLCN7 protein, human

Autor:innen und Institutionen

  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: lpolgreen@lundquist.org.
  • Departments of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Departments of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Departments of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

Förderung

  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institutes of Health

Zitieren

APA

Polgreen, L. E., Imel, E. A., & Econs, M. J. (2023). Autosomal dominant osteopetrosis. Bone, 170, 116723. https://doi.org/10.1016/j.bone.2023.116723

Vancouver

Polgreen LE, Imel EA, Econs MJ. Autosomal dominant osteopetrosis. Bone. 2023;170:116723. doi:10.1016/j.bone.2023.116723

BibTeX
@article{Polgreen2023,
  author = {Polgreen, Lynda E and Imel, Erik A and Econs, Michael J},
  title = {Autosomal dominant osteopetrosis},
  journal = {Bone},
  year = {2023},
  volume = {170},
  pages = {116723},
  doi = {10.1016/j.bone.2023.116723}
}
Kostenlos starten →